- Home
- GRC vs OCUL Comparison
GRC vs OCUL Comparison
Compare GRC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRC
- OCUL
- Stock Information
- Founded
- GRC 1933
- OCUL 2006
- Country
- GRC United States
- OCUL United States
- Employees
- GRC N/A
- OCUL N/A
- Industry
- GRC Fluid Controls
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- GRC Industrials
- OCUL Health Care
- Exchange
- GRC Nasdaq
- OCUL Nasdaq
- Market Cap
- GRC 1.0B
- OCUL 957.3M
- IPO Year
- GRC N/A
- OCUL 2014
- Fundamental
- Price
- GRC $37.18
- OCUL $9.02
- Analyst Decision
- GRC
- OCUL Strong Buy
- Analyst Count
- GRC 0
- OCUL 10
- Target Price
- GRC N/A
- OCUL $16.11
- AVG Volume (30 Days)
- GRC 52.4K
- OCUL 1.8M
- Earning Date
- GRC 07-25-2025
- OCUL 05-05-2025
- Dividend Yield
- GRC 1.99%
- OCUL N/A
- EPS Growth
- GRC 21.97
- OCUL N/A
- EPS
- GRC 1.69
- OCUL N/A
- Revenue
- GRC $664,347,000.00
- OCUL $59,647,000.00
- Revenue This Year
- GRC $4.50
- OCUL N/A
- Revenue Next Year
- GRC $4.50
- OCUL $20.05
- P/E Ratio
- GRC $22.00
- OCUL N/A
- Revenue Growth
- GRC 0.92
- OCUL N/A
- 52 Week Low
- GRC $30.87
- OCUL $4.79
- 52 Week High
- GRC $43.79
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- GRC 52.97
- OCUL 67.24
- Support Level
- GRC $36.71
- OCUL $6.86
- Resistance Level
- GRC $37.69
- OCUL $8.63
- Average True Range (ATR)
- GRC 0.65
- OCUL 0.50
- MACD
- GRC -0.12
- OCUL 0.15
- Stochastic Oscillator
- GRC 44.52
- OCUL 99.31
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.